A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients
[Paper-level Aggregated] PMCID: PMC3287118
Evidence Type(s): Oncogenic
Summary: Mutation: L858R | Summary: The L858R mutation is associated with tumor development or progression as it is mentioned in the context of samples with other mutations indicative of cancer.
Evidence Type: Oncogenic Mutation: T790M | Summary: The T790M mutation is associated with tumor development or progression as it is mentioned in the context of samples with other mutations indicative of cancer.
Evidence Type: Oncogenic Mutation: L861Q | Summary: The L861Q mutation is associated with tumor development or progression as it is mentioned in the context of samples with other mutations indicative of cancer.
Evidence Type: Oncogenic Mutation: S768I | Summary: The S768I mutation is associated with tumor development or progression as it is mentioned in the context of samples with other mutations indicative of cancer.
Gene→Variant (gene-first): EGFR(1956):L858R EGFR(1956):T790M EGFR(1956):L861Q EGFR(1956):S768I
Genes: EGFR(1956)
Variants: L858R T790M L861Q S768I